Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10064	Companies
205713	Keywords
135952	Articles
109063	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 01/09/2025 at 01:05, 1 year 2 months ago

Onco-Innovations obtient une licence exclusive pour les inhibiteurs de la PNKP dans le traitement du cancer

Traitement Du Cancer Essais De La FDA Innovations Oncologiques Inhibiteurs De La PNKP Marché De L'oncologie
PRESS RELEASE

published on 01/09/2025 at 01:00, 1 year 2 months ago

Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options
Onco-Innovations Limited announces exclusive-licensed PNKP inhibitors Technology targeting cancer cells to enhance treatment effectiveness across various cancer types including colorectal, breast, and lung cancer

Clinical Trials Cancer Treatment Oncology Market Onco-Innovations Limited PNKP Inhibitors Technology

Accesswire

Published on 03/23/2026 at 12:00, 14 minutes ago

Churchill Consolidates High-Grade Gold-Antimony Footprint in Central Newfoundland; Enters Option for 100% of Golden Baie
Published on 03/23/2026 at 11:30, 44 minutes ago

Trans Canada Gold Provides Update on Non-Brokered Private Placement and Flow-through Private Placement for Drilling at the Harrison Lake District Scale Gold Property Acquisition
Published on 03/23/2026 at 08:00, 4 hours 14 minutes ago

ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 10 hours 14 minutes ago

FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 23:00, 2 days 13 hours ago

Cypher Announces Private Placement

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 11:44, 29 minutes ago

Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
Published on 03/23/2026 at 11:30, 44 minutes ago

EQS Group lance un module de gestion des risques pour faciliter la surveillance continue des risques liées aux données et à l’IA
Published on 03/23/2026 at 11:06, 1 hour 7 minutes ago

Aroundtown SA: Release of a capital market information
Published on 03/23/2026 at 11:05, 1 hour 8 minutes ago

ASUS Unveils Complete Portfolio Support for Intel® Core™ 200S Series
Published on 03/23/2026 at 11:05, 1 hour 9 minutes ago

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology

Les Echos

Published on 03/23/2026 at 08:10, 4 hours 4 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 17 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 17 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 17 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 17 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE